On arrival to the ED, VS T97.1, HR145, BP94/49, RR32, satting 90%on NRB.
She received 2L NS, 6mg MS IV, Levaquin 500mg x1, Ceftriaxone 2g IV x1.
-[**2162**]: Treated with epirubicin/taxotere after found to have adrenal met -[**2162**]-[**2164**]: On Arimidex, then found to have liver mets -[**2164**]: Started on Xeloda -[**2165**]: Treated with taxol -[**2165**]: Phase II study of [**Doctor First Name **] [**Numeric Identifier 99361**] (tyrosine kinase inhibitor) -[**2165**]: Cancer metastasized to liver and adrenals -[**2166**]: Has received 2 treatments with gemcitabine [**2167-8-28**]: thoracentesis with fluid positive for malignant cells [**2167-10-16**]: Right VATS, talc pleurodesis by Dr. [**Last Name (STitle) 952**] with placement of pleur-X cath [**2167-10-30**]: 3rd dose of Gemcitabine Currently treated w/ Navelbine, last dose 2 wks ago.
Lung CA:  father, sister   Physical Exam: VS: T95.5  HR135  BP 104/78  RR 28 o2sat: 96% on 4L NC GEN: Appears stated age, mild discomfort due to pain, able to speak in full sentences HEENT: Anicteric sclera bilat.
Nml s1,s2.
Imaging: ECHO [**6-3**]: EF >60%.
Left ventricular wall thicknesses are normal.
Overall left ventricular systolic function is normal (LVEF>55%).
CT Torso c contrast [**6-3**]: 1.
Interval [**Month/Day (4) 9140**] in now moderate-to-severe ascites and increased omental soft tissue consistent with [**Month/Day (4) 9140**] omental carcinomatosis.
Her SOB appears to be at her baseline.
#L CHEST/ABD PAIN This likely represented an element of musculoskeletal pain from osteolytic lesions as seen on CT torso, with a component of hypercalcemia.
She had no evidence of new/[**Month/Day (4) 9140**] PE burden on CT torso.
She underwent paracentesis in the ED with removal of 3L to make the patient more comfortable.
She was given pamidronate 90 mg IV, with some response in her calcium levels.
CT torso today revealed [**Month/Day (4) 9140**] metastatic disease with [**Month/Day (4) 9140**] omental carcinomatosis.
Followup Instructions: Provider: [**Name10 (NameIs) 251**] [**Last Name (NamePattern4) 15108**], MD Phone:[**Telephone/Fax (1) 22**] Date/Time:[**2168-6-22**] 1:00 Provider: [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 4425**], RN Phone:[**Telephone/Fax (1) 22**] Date/Time:[**2168-6-22**] 1:30                                [**First Name8 (NamePattern2) 251**] [**Name8 (MD) **] MD [**MD Number(1) 3282**]
